Delivery Order SPE2DB24D1104-SPE2DB25FYDF2
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,167.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 ml auto-injector units, with a completion date of September 15, 2025. This non-set-aside competitive award represents a single delivery order transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.80 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector units on July 28, 2025, with completion expected by July 29, 2025. This delivery order represents a firm fixed-price purchase with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency has awarded a delivery order valued at $1,067.72 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector pharmaceutical supplies, valued at $1,865.12 with a firm fixed price contract type. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 4, 2025, with fulfillment based at the vendor's Conshohocken, Pennsylvania location. This delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.31 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. This competitively awarded, firm fixed-price contract was issued on June 4, 2025, with an ultimate completion date of June 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award, indicating open competition among qualified...
- The Defense Logistics Agency awarded a $2,665.27 delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector supplies on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded order fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $1,494.88 delivery order to AmerisourceBergen Drug Corp for XYOSTED 50 mg/0.5 mL auto-injector supplies, with an ultimate completion date of June 20, 2025. This non-set-aside, firm fixed price delivery order was issued on June 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,203.36 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,150.15 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. The contract, which is non-set-aside and competitively awarded, was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order operates under...
- The Defense Logistics Agency (DLA) awarded a $1,629.66 delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on May 8, 2025, with completion scheduled for May 9, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office...